e1 id: E113; e2 id: T7; e1 text: head MRI; e2 text: November 20
ground truth: AFTER; prediction: BEFORE

e1 id: E33; e2 id: E179; e1 text: azithromycin; e2 text: ID consult
ground truth: AFTER; prediction: BEFORE

e1 id: E34; e2 id: E179; e1 text: itraconazole; e2 text: ID consult
ground truth: AFTER; prediction: BEFORE

e1 id: E35; e2 id: E179; e1 text: pentamidine; e2 text: ID consult
ground truth: AFTER; prediction: BEFORE

e1 id: E34; e2 id: E39; e1 text: itraconazole; e2 text: itraconazole
ground truth: OVERLAP; prediction: BEFORE

e1 id: E37; e2 id: E33; e1 text: azithromycin; e2 text: azithromycin
ground truth: OVERLAP; prediction: BEFORE

e1 id: E57; e2 id: E55; e1 text: previous baseline creatinine; e2 text: acute renal failure
ground truth: BEFORE; prediction: OVERLAP

e1 id: E187; e2 id: E158; e1 text: creatinine; e2 text: discharge
ground truth: BEFORE; prediction: OVERLAP

e1 id: E61; e2 id: E187; e1 text: peak creatinine; e2 text: creatinine
ground truth: BEFORE; prediction: OVERLAP

e1 id: E58; e2 id: E55; e1 text: Kayexalate; e2 text: acute renal failure
ground truth: OVERLAP; prediction: BEFORE

e1 id: E213; e2 id: E122; e1 text: progressive Acanthamoeba infection; e2 text: fevers
ground truth: BEFORE; prediction: OVERLAP

e1 id: E145; e2 id: E144; e1 text: pain; e2 text: morphine
ground truth: BEFORE; prediction: OVERLAP

e1 id: E146; e2 id: E144; e1 text: air hunger; e2 text: morphine
ground truth: BEFORE; prediction: OVERLAP

e1 id: E156; e2 id: T5; e1 text: hospitalized; e2 text: November 11
ground truth: BEFORE; prediction: OVERLAP

e1 id: E177; e2 id: E156; e1 text: Acanthamoeba infection of skin; e2 text: hospitalized
ground truth: BEFORE; prediction: OVERLAP

e1 id: E156; e2 id: T4; e1 text: hospitalized; e2 text: September 26
ground truth: AFTER; prediction: OVERLAP

e1 id: E179; e2 id: E29; e1 text: ID consult; e2 text: skin biopsy
ground truth: AFTER; prediction: BEFORE

e1 id: E74; e2 id: E194; e1 text: cough; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E75; e2 id: E194; e1 text: shortness of breath; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E76; e2 id: E194; e1 text: chest pain; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E77; e2 id: E194; e1 text: nausea; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E78; e2 id: E194; e1 text: vomiting; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E79; e2 id: E194; e1 text: diarrhea; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E80; e2 id: E194; e1 text: dysuria; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E81; e2 id: E194; e1 text: neck stiffness; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E82; e2 id: E194; e1 text: new skin lesions; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E83; e2 id: E194; e1 text: worsening red petechiae; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E84; e2 id: E194; e1 text: increasing sinus symptoms; e2 text: reports
ground truth: BEFORE; prediction: OVERLAP

e1 id: E226; e2 id: E152; e1 text: inflammation; e2 text: prednisone
ground truth: BEFORE; prediction: OVERLAP

e1 id: E227; e2 id: E152; e1 text: adrenal insufficiency; e2 text: prednisone
ground truth: BEFORE; prediction: OVERLAP

e1 id: E228; e2 id: T9; e1 text: comfortable; e2 text: December 3
ground truth: BEFORE; prediction: OVERLAP

e1 id: E23; e2 id: E19; e1 text: Campath; e2 text: bone marrow biopsy
ground truth: AFTER; prediction: BEFORE

e1 id: E26; e2 id: E19; e1 text: CT scan; e2 text: bone marrow biopsy
ground truth: AFTER; prediction: OVERLAP

e1 id: E211; e2 id: E119; e1 text: cyclosporine; e2 text: cerebritis
ground truth: BEFORE; prediction: AFTER

e1 id: E211; e2 id: E118; e1 text: cyclosporine; e2 text: cyclosporine
ground truth: OVERLAP; prediction: AFTER

e1 id: E221; e2 id: E217; e1 text: Levaquin; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E222; e2 id: E217; e1 text: acyclovir; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E223; e2 id: E217; e1 text: GCSF; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E224; e2 id: E217; e1 text: other medications; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E166; e2 id: E165; e1 text: Acanthamoeba infection of skin; e2 text: stay
ground truth: BEFORE; prediction: OVERLAP

e1 id: T0; e2 id: E1; e1 text: nine months; e2 text: non-myeloblative stem cell transplant
ground truth: AFTER; prediction: OVERLAP

e1 id: E52; e2 id: E40; e1 text: valganciclovir maintenance suppression; e2 text: voriconazole
ground truth: OVERLAP; prediction: BEFORE

e1 id: E94; e2 id: E93; e1 text: coagulase negative Staphylococcus; e2 text: a blood culture
ground truth: BEFORE; prediction: OVERLAP

e1 id: E95; e2 id: E87; e1 text: A repeat CMV hypercapture; e2 text: Workup on admission
ground truth: AFTER; prediction: BEFORE

e1 id: E11; e2 id: T12; e1 text: leukemic phase; e2 text: November , 2001
ground truth: AFTER; prediction: OVERLAP

e1 id: E143; e2 id: E217; e1 text: aggressive measures of care; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: T18; e2 id: E204; e1 text: the days; e2 text: admission
ground truth: AFTER; prediction: BEFORE

e1 id: E207; e2 id: E204; e1 text: Infectious disease consult; e2 text: admission
ground truth: AFTER; prediction: BEFORE

e1 id: E72; e2 id: E159; e1 text: rehabilitation; e2 text: discharge
ground truth: AFTER; prediction: BEFORE

e1 id: E96; e2 id: E202; e1 text: A repeat CAT scan of the sinuses; e2 text: prior study
ground truth: AFTER; prediction: BEFORE

e1 id: E37; e2 id: E38; e1 text: azithromycin; e2 text: trial of 5-FC
ground truth: BEFORE; prediction: OVERLAP

e1 id: E38; e2 id: E180; e1 text: trial of 5-FC; e2 text: increasing neutropenia
ground truth: BEFORE; prediction: OVERLAP

e1 id: E40; e2 id: E39; e1 text: voriconazole; e2 text: itraconazole
ground truth: AFTER; prediction: BEFORE

e1 id: E47; e2 id: E39; e1 text: re-CT of sinuses; e2 text: itraconazole
ground truth: AFTER; prediction: BEFORE

e1 id: E41; e2 id: E39; e1 text: continued neutropenia; e2 text: itraconazole
ground truth: OVERLAP; prediction: BEFORE

e1 id: E42; e2 id: E40; e1 text: sulfadiazine; e2 text: voriconazole
ground truth: OVERLAP; prediction: BEFORE

e1 id: E87; e2 id: E87; e1 text: Workup on admission; e2 text: Workup on admission
ground truth: AFTER; prediction: OVERLAP
This relation involves in BBB

e1 id: E198; e2 id: E90; e1 text: abscess; e2 text: an MRI of the liver
ground truth: BEFORE; prediction: OVERLAP

e1 id: E92; e2 id: E87; e1 text: Blood and urine cultures; e2 text: Workup on admission
ground truth: AFTER; prediction: OVERLAP
This relation involves in BBB

e1 id: E183; e2 id: E52; e1 text: inability to tolerate; e2 text: valganciclovir maintenance suppression
ground truth: OVERLAP; prediction: AFTER

e1 id: E53; e2 id: E183; e1 text: increasing ARS; e2 text: inability to tolerate
ground truth: OVERLAP; prediction: BEFORE

e1 id: E127; e2 id: E124; e1 text: a PICC line; e2 text: A single blood culture
ground truth: BEFORE; prediction: OVERLAP

e1 id: E126; e2 id: E124; e1 text: vancomycin; e2 text: A single blood culture
ground truth: AFTER; prediction: BEFORE

e1 id: E130; e2 id: E128; e1 text: levofloxacin; e2 text: a chest x-ray
ground truth: AFTER; prediction: BEFORE

e1 id: E108; e2 id: E102; e1 text: maximal antimicrobial therapy; e2 text: voriconazole
ground truth: OVERLAP; prediction: BEFORE

e1 id: E14; e2 id: T13; e1 text: Campath; e2 text: July , 2001
ground truth: AFTER; prediction: OVERLAP

e1 id: E15; e2 id: E14; e1 text: lymphopenia; e2 text: Campath
ground truth: OVERLAP; prediction: BEFORE

e1 id: E16; e2 id: E14; e1 text: neutropenia; e2 text: Campath
ground truth: OVERLAP; prediction: BEFORE

e1 id: E85; e2 id: E160; e1 text: treatment; e2 text: admitted
ground truth: AFTER; prediction: OVERLAP

e1 id: E174; e2 id: T2; e1 text: did well; e2 text: 1997
ground truth: BEFORE; prediction: AFTER

e1 id: E10; e2 id: T2; e1 text: progressive disease; e2 text: 1997
ground truth: BEFORE; prediction: AFTER

e1 id: E173; e2 id: T10; e1 text: presented; e2 text: 1991
ground truth: OVERLAP; prediction: BEFORE

e1 id: E7; e2 id: T10; e1 text: MACE; e2 text: 1991
ground truth: OVERLAP; prediction: BEFORE

e1 id: E8; e2 id: E7; e1 text: CytaBOM; e2 text: MACE
ground truth: OVERLAP; prediction: AFTER

e1 id: T11; e2 id: E9; e1 text: six cycles; e2 text: fludarabine
ground truth: OVERLAP; prediction: AFTER

e1 id: E9; e2 id: T2; e1 text: fludarabine; e2 text: 1997
ground truth: OVERLAP; prediction: AFTER

e1 id: E103; e2 id: E207; e1 text: itraconazole; e2 text: Infectious disease consult
ground truth: AFTER; prediction: BEFORE

e1 id: E104; e2 id: E102; e1 text: treatment; e2 text: voriconazole
ground truth: OVERLAP; prediction: BEFORE

